Israel files patents for 8 coronavirus antibodies

The Israel Institute for Biological Research has filed patent requests for eight types of coronavirus antibodies that it has isolated, according to Defense Minister Naftali Bennett

The antibodies will be used for the development of a future drug to treat the disease caused by COVID-19.

Bennett said he was briefed on the development by Shmuel Shapira, who heads IIBR’s Ness Ziona facility. He called the move “another important step in developing a cure. IIBR is working around the clock to find a life-saving solution.”

Earlier this month, the Defense Ministry revealed that IIBR had completed a groundbreaking scientific development, identifying an antibody that neutralizes the coronavirus, a development that Bennett called “a major breakthrough.”